[141 MD in the treatment of the capillary fragility in diabetic patients. 60 cases].
D000328:Adult; D002198:Capillary Fragility / Q000187:drug effects*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D005021:Ethylamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013451:Sulfonic Acids / Q000627:therapeutic use*
Le 141 MD dans le traitement de la fragilité capillaire des diabétiques. A propos de 60 cas.